Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,454,385
+$511,390 QoQ
Shares Held
76,628
+12.9% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#104
of 329 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $430,307,229 across 249 Biotechnology names. PCVX ranks #17 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
402,605 | $31,511,893 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
90,543 | $30,312,890 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
58,072 | $28,846,104 | |
| 4 | FTRE |
Fortrea Holdings Inc.
|
1,362,169 | $23,701,740 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
89,662 | $21,946,567 | |
| 6 | IMNM |
Immunome Inc.
|
859,076 | $18,203,820 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,880 | $14,266,595 | |
| 8 | CYTK |
Cytokinetics Inc
|
140,046 | $11,930,518 |
All Filings in PCVX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,454,385 | 76,628 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,942,995 | 67,854 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $2,944,054 | 63,807 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $2,397,707 | 66,566 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,437,177 | 74,967 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,725,818 | 72,188 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $6,098,815 | 74,503 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $7,751,276 | 67,833 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $4,754,638 | 62,967 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,688,535 | 53,997 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $3,094,218 | 49,271 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $2,511,835 | 49,271 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $2,419,343 | 48,445 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $1,408,348 | 37,576 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $1,801,769 | 37,576 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $660,552 | 27,523 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $598,900 | 27,523 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $572,089 | 23,689 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $355,565 | 14,946 | Shares | Defined | 2024-05-17 | |
| 2021-09-30 | $379,180 | 14,946 | Shares | Defined | 2024-05-17 | |
| 2021-06-30 | $336,434 | 14,946 | Shares | Defined | 2024-05-17 | |
| 2021-03-31 | $231,233 | 11,708 | Shares | Defined | 2024-05-17 | |
| 2020-12-31 | $208,893 | 7,862 | Shares | Defined | 2024-05-24 | |
| 2020-09-30 | $388,225 | 7,862 | Shares | Defined | 2024-05-24 | |
| No filing history on record for this holder in this stock. | ||||||